TissueGnostics wins 1st prize for image analysis software


We proudly announce that TissueGnostics has won the 1st Place in the International Scanner Contest 2016 that took place in Berlin, May 25th to 28th.

Robert Nica has represented our company in the category „Image Analysis“ and convinced an international scientific committee with an excellent and groundbreaking software. The decision was made by the Charite Berlin Germany, the University of Applied Sciences Brandenburg, the Hospital de Jerez de la Frontera Spain, the National Centre of Pathology Lithuania, the University of Freiburg in Germany and the Massachusetts General Hospital USA and clearly confirmed TissueGnostics successful future-oriented work.

Sincere thanks both to Robert Nica for his personal effort and to the TissueGnostics global team for the excellent support and teamwork!

CU next year again - we accept the challenge!


Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    TissueGnostics. (2019, June 19). TissueGnostics wins 1st prize for image analysis software. News-Medical. Retrieved on May 26, 2024 from https://www.news-medical.net/news/20171201/TissueGnostics-wins-1st-prize-for-image-analysis-software.aspx.

  • MLA

    TissueGnostics. "TissueGnostics wins 1st prize for image analysis software". News-Medical. 26 May 2024. <https://www.news-medical.net/news/20171201/TissueGnostics-wins-1st-prize-for-image-analysis-software.aspx>.

  • Chicago

    TissueGnostics. "TissueGnostics wins 1st prize for image analysis software". News-Medical. https://www.news-medical.net/news/20171201/TissueGnostics-wins-1st-prize-for-image-analysis-software.aspx. (accessed May 26, 2024).

  • Harvard

    TissueGnostics. 2019. TissueGnostics wins 1st prize for image analysis software. News-Medical, viewed 26 May 2024, https://www.news-medical.net/news/20171201/TissueGnostics-wins-1st-prize-for-image-analysis-software.aspx.


The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Investigating IDO1 and PDL1: Key immune checkpoints in cutaneous leishmaniasis research